Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Tumor Progression02:07

Tumor Progression

3.6K
3.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.1K
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discussion: Principles and Techniques to Reduce the Incidence of Fistula: A Review of over 1000 Cleft Palate Repairs by a Single Surgeon.

Plastic and reconstructive surgery·2026
Same author

Diagnosis and Treatment of Lymphatic Complications of the Groin Following Open Lower Extremity Revascularization with Plastic Surgery Closure.

Annals of vascular surgery·2021
Same author

TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors.

Cancer genetics·2021
Same author

Prophylactic Muscle Flaps in Primary Vascular Procedures of the Groin.

Annals of vascular surgery·2021
Same author

Facial Feminization Surgery: Key CT Findings for Preoperative Planning and Postoperative Evaluation.

AJR. American journal of roentgenology·2020
Same author

Facial Feminization Surgery: Key CT Findings for Preoperative Planning and Postoperative Evaluation.

AJR. American journal of roentgenology·2020
Same journal

Institutional Learning Curve in Esophagectomy: Technical Standardization of Gastric Conduit Formation and Conduit-Related Outcomes in 187 Consecutive Patients.

Journal of surgical oncology·2026
Same journal

Evaluating the Accuracy of ChatGPT-4o in Addressing Complex Clinical Questions Based on NCCN Guidelines for Rectal Adenocarcinoma.

Journal of surgical oncology·2026
Same journal

Racial Differences in Breast Cancer Treatment and Information Access.

Journal of surgical oncology·2026
Same journal

Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

Journal of surgical oncology·2026
Same journal

The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

Journal of surgical oncology·2026
Same journal

"It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

Journal of surgical oncology·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K

Contemporary diagnostics: sarcoma pathology update.

John S J Brooks1, Solomon Lee

  • 1Perlman School of Medicine, University of Pennsylvania, Chair of Pathology, Pennsylvania Hospital of the University of Pennsylvania Health System, Philadelphia, Pennsylvania; Pennsylvania Hospital of the University of Pennsylvania Health System, Philadelphia, Pennsylvania.

Journal of Surgical Oncology
|February 19, 2015
PubMed
Summary
This summary is machine-generated.

Sarcoma diagnosis is advancing with new tumor classifications and updated terminology. Novel immunostains and risk assessment models improve diagnostic specificity and prognostic accuracy for sarcomas.

Keywords:
immunohistochemistrynew entitiesnew markersrisk assessmentsarcoma

More Related Videos

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.5K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.4K

Related Experiment Videos

Last Updated: Apr 17, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.5K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.4K

Area of Science:

  • Oncology
  • Pathology

Background:

  • Sarcoma diagnosis and classification are dynamic fields.
  • Traditional diagnostic criteria and terminology are being revised based on new research.

Purpose of the Study:

  • To outline recent advancements in sarcoma diagnosis.
  • To highlight newly recognized entities and outdated terms.
  • To discuss the role of novel diagnostic tools and prognostic models.

Main Methods:

  • Review of current literature and diagnostic guidelines.
  • Identification of newly described sarcoma entities.
  • Evaluation of emerging immunostains and risk stratification methods.

Main Results:

  • Specific tumors like dermal leiomyosarcoma have been reclassified.
  • New entities such as myxoinflammatory fibroblastic sarcoma, myoepithelioma, and pseudomyogenic hemangioendothelioma are recognized.
  • Outdated terms like malignant fibrous histiocytoma and hemangiopericytoma are no longer recommended.
  • Immunostains including STAT6, SOX10, and ERG enhance diagnostic precision.
  • Novel risk assessment models offer improved prognosis where grading and staging are insufficient.

Conclusions:

  • Sarcoma diagnosis requires continuous updates to classification and terminology.
  • Emerging immunostains and risk models are crucial for accurate sarcoma diagnosis and prognosis.
  • Adoption of new diagnostic standards ensures precise patient management.